5/23/02Dr C Davis, SOTA 2002, June 10- 14, 2002 Community TB Care Making DOTS More Accessible.

Slides:



Advertisements
Similar presentations
From "3 by 5" to Universal Access
Advertisements

STEPPING UP THE RESPONSE Roxana Rogers Acting, Deputy Office of HIV/AIDS Bureau for Global Health U.S. Agency for International Development.
Repositioning Family Planning in Africa Africa SOTA Nairobi June 10-15, 2002.
School of Public Health
By Dr Ashraf Mohammed: HOD HIV/AIDS Unit, CPUT Dr Nazeema Mohamed: Transformation Officer, Wits University : Positioning HR as a Strategic Driver for HEI.
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Closing the MGD Gap Through Health Literacy Working With Civil Society and Communities Dr Bernhard Schwartländer ECOSOC Annual Ministerial Review Regional.
SERVICE DELIVERY AS AN ENTRY POINT TO HEALTH SYSTEM STRENGTHENING A Case Study from Senegal: Improving the Tuberculosis System of Care Dr. Bruno Bouchet,
HIV/AIDS Weakens the Immune System
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
EPIDIOMOLGY OF HIV IN NIGERIA by Dr Ibrahim M Kida.
Improving Depression Treatment in Primary Care: Dissemination and Implementation Edmund Chaney, PhD Department of Veterans Affairs, Seattle AcademyHealth.
2008 Report on the global AIDS epidemic Report on the global AIDS epidemic A global view of HIV infection 33 million people [30–36 million] living.
1. 2 Why are Result & Impact Indicators Needed? To better understand the positive/negative results of EC aid. The main questions are: 1.What change is.
DOTS/ DOTS PLUS IMPLEMENTATION AND INTEGRATION Vaira Leimane State Centre of Tuberculosis and Lung Diseases of Latvia Paris, October, 28.
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Group III: Demand Forecasting
1  1 =.
First cases of AIDS identified.
Malaria Figures 3.3 billion people at risk of malaria in billion at high risk (>1 case/1000 population) mainly in the WHO African (49%) and South.
School Shop. Welcome to my shop. You have 10p How much change will you get? 7p 3p change.
Our vision is a world free from TB. Our mission is to address the health, social and economic impact of the global TB epidemic amongst vulnerable and.
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
Unit 1. Introduction TB Infection Control Training for Managers at the National and Subnational Levels.
Antiretroviral Therapy: An HIV Prevention Strategy? Wafaa El-Sadr, MD, MPH Columbia University Harlem Hospital New York.
Module 11: Community TB Care Image source: Pierre Virot, World Lung Foundation.
TB/HIV Integration What it entails Frank Lule, Eyerusalem Negussie, Reuben Granich, Haileyesus Getahun.
Exploring Synergies Health Systems and Sustainability TB/HIV collaboration Alasdair Reid UNAIDS Pretoria International Multistakeholder Consultation on.
From DOTS to the Stop TB Strategy Building on Achievements for Future Planning Stop TB Partnership Symposium at the 37 th UNION World Conference on TB.
PPM-DOTS in Cambodia Working with Private Pharmacies DOTS Expansion WG Meeting Paris 15 th October 2008 Dr. Mao Tan Eang Director National Center for TB.
Involving all health care providers in collaborative TB/HIV activities Eva Nathanson PPM subgroup meeting Cairo, Egypt, 3-5 June 2008.
PPM SUBGROUP MEETING Cairo, 3-5 June 2008 Involving all health care providers in the MDR and XDR-TB response Matteo Zignol Stop TB Department World Health.
MiMOSA Training 1. Opening 2. TB WRx and the 2007 DS Forms 3. Data entry and report generation for the new DS forms 4. Mission settings for DS Forms 5.
Monitoring PPM contributions – from operational research to regular reporting Knut Lönnroth Stop TB Department 5 th PPM Subgroup Meeting Cairo, 4 June.
World Health Organization Department of HIV/AIDS Estimates of ARV Treatment Needs
The TB situation in the Americas: Reaching the MDGs on TB Dr. Jarbas Barbosa Area Manager, Health Surveillance & Disease Management 23 March 2007.
The Future of HIV Diagnostics: Market Trends for CD4 and VL Testing Decade of Diagnostics Satellite Kuala Lumpur July 2, 2013.
Key elements to develop a national strategic plan for TB control Malgosia Grzemska Stop TB Department WHO, Geneva, Switzerland EURO/TBTEAM Regional Workshop.
Deputy Director, Social Care Policy
Treatment as Prevention (TasP)
THE CHALLENGE: CHRONIC DISEASE CARE AND THE PROMISE OF HIT Health Care Information Technology 2004: Improving Chronic Care in California San Francisco.
ADAPTATION OF THE WHO/UNICEF COMMUNITY HEALTH WORKER MATERIALS TO INCLUDE HIV AND TB Presented by Sandy Reid World Health Organization.
Monitoring and Evaluation of VCT programs
Engaging workplaces in TB care and control Evidence base and guidance framework Hannah Monica Yesudian Dias Stop TB Department World Health Organization.
Mobile clinics: How to improve access to health in remote areas? WHO Informal Technical Consultation BRAVE Geneva 6-7 November 2012 Dr Charles Senessie.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
National TB/ Leprosy Programme Manager
Africa Herbal Antimalaria Meeting Nairobi, March 2006 Research on Traditional Medicines used for the Treatment of Malaria in WHO African Region Traditional.
Challenge 4: Linking TB & HIV/AIDS Programs Kayt Erdahl, Project HOPE Rodrick Nalikungwi, Project HOPE Malawi December 18, 2008.
Palliative care and pain treatment in Zithulele Hospital and surrounding area 30 September 2011 Annette Dekker Health Grand Challenge Summer of Learning.
Antiretroviral Treatment (ART) & Human resources Wim Van Damme Department of Public Health ITM, 17 October 2006.
Progress of the Singapore TB Elimination Programme (STEP)
Dr. Hind E. Satti Partners In Health, Lesotho March, 2008.
Providing Treatment, Restoring Hope Program Updates Dr. Robb Sheneberger, MD University of Maryland School of Medicine Track 1.0 Implementers Meeting Dar.
AFRICA HIV/AIDS AIDS DATA SOURCE: UNAIDS 2007 REPORT WORLD HEALTH ORGANIZATION.
1 Partnering to Strengthen Local Efforts Can Help Us Get to Six Million on ART Anja Giphart, MD MPH Vice President, Program Implementation Elizabeth Glaser.
Philippe Chiliade, MD, MHA Technical Advisor, Clinical Care, FHI 12 August 2008 Family Health International Implementing HIV Care & Treatment Progress.
Investing in Different Models of Local Ownership to Ensure Sustainable Patient Care Track 1 Implementers Meeting Maputo, Mozambique August
Challenges of Intensified TB case finding among PLHIV : Kenyan experience Dr. J. Sitienei Ministry of Health Kenya.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Number of people receiving antiretroviral therapy in
Tuberculosis and the President’s Emergency Plan for AIDS Relief
The role of the community in TB control
C R E A E Consortium to Respond Effectively to the AIDS-TB Epidemic
TB in South Africa.
ProTEST Lessons Learned Workshop
Presentation for Second Meeting of the Global TB/HIV Working Group
Routine Counselling and HIV testing (CT) for TB patients in Malawi: Rhehab Chimzizi TB-HIV Programme officer National TB Control Programme-Malawi.
Fabio Scano IUATLD Conference Paris, 2003
33rd IUATLD World Conference on Lung Health
Presentation transcript:

5/23/02Dr C Davis, SOTA 2002, June , 2002 Community TB Care Making DOTS More Accessible

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Why Community TB Care Initiative Was Needed Sub-Saharan Africa has some of the highest TB case rates in the world, Countries with high prevalence for HIV, have experienced huge increases in notified TB cases, Traditional TB treatment policies - focused on hospital Rx during intensive phase - Health workers deliver TB treatment

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Why Community TB Care Needed - Congestion in hospital wards and medical departments - Overstretched resources (I.e. human, material, financial) - Patient dissatisfaction with long separation from family

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Dynamics of TB and HIV in Kenya TB incidence/100, HIV pevalence adults (%) TB HIV national HIV Nairobi

5/23/02 Dr C Davis, SOTA 2002, June , 2002 PILOTING THE COMMUNITY TB CARE INITIATIVE WHO in collaboration with partners (CDC, USAID, IUATLD, KNCV, UNAIDS) implemented some operations research Objective was to evaluate the effectiveness, acceptability, affordability, and cost-effectiveness of community-based TB care Eight district based projects developed in six countries (Botswana, Kenya, Malawi, South Africa, Uganda and Zambia). Study from

5/23/02 KEY FEATURES OF THE COMMUNITY TB CARE PILOT PROJECTS CountryProject SiteSettingStudy designComm. org. BotswanaFrancistownUrbanHist case control study HIV/AIDS HBC group KenyaMachakosRuralHist. case control study PHC volunteer CBDs MalawiLilongweUrbanHist. case control study Guardians and CHWs South AfricaGuguletu, Cape Town UrbanHist. case control study Tuberculosis NGO Hlabisa, Kwazulu RuralProspect. controlled Traditional healers UgandaKiboga Kawempe Rural Urban Hist case control study Prosp. contr Parish Dev. Committee HIV NGO ZambiaNdolaUrbanProspective controlled Church NGO AIDS pgm

5/23/02 Dr C Davis, SOTA 2002, June , 2002 EVIDENCE FROM THE PILOT SITES GUGULETU, SOUTH AFRICA Designed to evaluate program performance and cost- effectiveness of various supervision options (clinic, community and other) for TB treatment. Major findings: -TB treatment outcomes were better for community supervised TB treatment, - Community supervision of treatment is more cost effective than wholly clinic based supervision

TREATMENT OUTCOMES FOR GUGULETU, SOUTH AFRICA SITE Treatment outcomes for new smear positive TB cases Outcome Clinic DOT Community Other* (n=338) (n=331) (n=54) Cured49% 70% Completed 9% 11% 68% Died 2% 1% 9% Defaulted23% 14% 5% Transferred 17% 5% 17% Failure 0 < 1% *=workplace, home/self, school, hospital Patients treated under community DOT were significantly more likely to have treatment success than patients treated in the clinic (RR 1.4, 95% CI , P<0.001) Treatment outcomes for retreatment smear positive TB cases OutcomeClinic DOTCommunityOther (n=215) (n=29)(n=8) Cured41%63%33% Completed12%10%15% Died 8% 3%19% Defaulted29%19%22% Transferred 9% 3% 11% Failure 0< 1% 0

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Guguletu, South Africa

5/23/02 Dr C Davis, SOTA 2002, June , 2002 EVIDENCE FROM THE PILOT SITES KIBOGA DISTRICT, UGANDA: Study designed to compare the cost-effectiveness of community TB care to conventional hospital based care Major findings: - Patients in the intervention group twice as likely to be treated successfully than those in the control group. - There were substantial reductions in cost and over 50% improvement in cost-effectiveness in the intervention group. - The approach was acceptable to patients, health care workers and the community. Major conclusion: Because of the success of this project, CB- DOTS has been adopted as a national policy since January 2000

5/23/02 Dr C Davis, SOTA 2002, June , 2002 KIBOGA SITE Before CBDOT option (%)After CBDOT option (%) Treatment outcomes * Cured76 (47.2)166 (63.4) Completed treatment19 (11.8) 28 (10.7) Failure 1 (0.6) 0 Died25 (15.5) 37 (14.1) Interrupted treatment31 (19.3) 4 (1.5) Transferred 9 (5.6) 27 (10.3) Total Treatment success 95 (59) 194 (74) *

Cost-effectiveness, KIBOGA

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Lessons Learned From Pilot Sites Community-based DOTS is feasible, acceptable, and cost-effective Successful CTBC requires close collaboration with NTP and the community Should only be implemented where there is a functioning NTP with the 5 elements of DOTS strategy in place Managerial expertise is essential; ensuring the decentralization of logistics for TB control (e.g. drug supply, reporting outcomes etc)

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Lessons Learned From Pilot Sites Sustainability of the program must be planned from the start. A good situation analysis is required to identify appropriate community care providers. Training and capacity building for the community structures are prerequisites for a successful CB-DOTS. While CB-DOTS is more cost-effective, new resources are required for training of care providers, setting up systems, patient follow-up and supervision. CTBC should complement and extend NTP capacity, not replace it. Effective CB-DOTS requires a strong reporting system, access to lab facilities, and a secure drug supply.

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Approaches To Promote Community TB Care Initiative in Africa Community TB Care is one of the strategies for DOTS expansion in the WHO/AFRO Regional TB Control Strategic Plan ( ) Guidelines for implementation of CB-DOTS are in final draft Scaling up of pilot projects within the countries concerned ( Kenya, Malawi, Uganda) Promotion/Dissemination of lessons learned in CTBC Initiative through sub-regional Workshops (Nairobi May 6-10, 2002)

5/23/02 Dr C Davis, SOTA 2002, June , 2002 Thank You